Suppr超能文献

[肾性尿崩症患者的分子生物学研究]

[Molecular biological studies on patients with nephrogenic diabetes insipidus].

作者信息

Szalai C, Molnár E, Sallay P, Czinner A

机构信息

Fövárosi Onkormányzat Heim Pál Gyermekkórház-Szakrendelö, Budapest.

出版信息

Orv Hetil. 1998 Apr 12;139(15):883-7.

PMID:9579101
Abstract

Nephrogenic diabetes insipidus is a rare, mostly X-linked recessive disorder characterised by renal tubular resistance to the antidiuretic effect of arginine vasopressin. The gene responsible for the X-linked nephrogenic diabetes insipidus, the G-protein-coupled vasopressin V2-receptor, has been localised on the Xq28 region. In this study four patients were investigated with molecular genetic methods. Diagnosis was based on clinical symptoms and lack of increase of urinary osmolality after administration of the arginine vasopressin, or the synthetic vasopressin analogue DDAVP. Three different mutations (C112R, N317K, W323S) were found in three patients, while no mutation was detected in the fourth patient. Since earlier histiocytosis X has been diagnosed in this patient, this patient has probably central diabetes insipidus. Although the main symptoms of the disease can be found in all patients, there are significant differences in the seriousness of the symptoms as well as in some other symptoms. The explanations might be the different mutations in the V2-receptor gene and the various other genetic and environmental factors; these findings provide further evidence that X-linked nephrogen diabetes insipidus results from defects in the V2-receptor gene.

摘要

肾性尿崩症是一种罕见的疾病,大多为X连锁隐性遗传,其特征是肾小管对精氨酸加压素的抗利尿作用产生抵抗。导致X连锁肾性尿崩症的基因,即G蛋白偶联的加压素V2受体,已定位在Xq28区域。在本研究中,对4例患者采用分子遗传学方法进行了研究。诊断基于临床症状以及给予精氨酸加压素或合成加压素类似物去氨加压素后尿渗透压未升高。在3例患者中发现了3种不同的突变(C112R、N317K、W323S),而第4例患者未检测到突变。由于该患者先前已被诊断为组织细胞增多症X,所以该患者可能患有中枢性尿崩症。尽管所有患者都有该疾病的主要症状,但症状的严重程度以及一些其他症状存在显著差异。其原因可能是V2受体基因的不同突变以及各种其他遗传和环境因素;这些发现进一步证明X连锁肾性尿崩症是由V2受体基因缺陷引起的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验